LHC Group Company Profile (NASDAQ:LHCG)

About LHC Group (NASDAQ:LHCG)

LHC Group, Inc. is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services. Through its home health services segment, the Company offers a range of services, including skilled nursing, medically oriented social services, and physical, occupational and speech therapy. Through its hospice services segment, the Company offers a range of services, including pain and symptom management, and emotional and spiritual support. Its community-based service operations offer a range of services to patients in their home or in a medical facility. The services range from assistance with grooming, medication reminders and meal preparation. It provides facility-based services principally through its LTACHs.

Industry, Sector and Symbol:

Sector: Medical
Industry: Ambulance & Emergency Services
Sub-Industry: Health Care Services
Symbol: NASDAQ:LHCG
CUSIP: 50187A10
Web: www.lhcgroup.com

Capitalization:

Market Cap: $1.18 billion
Outstanding Shares: 18,282,000

Average Prices:

50 Day Moving Avg: $63.81
200 Day Moving Avg: $60.05
52 Week Range: $32.04 - $69.35

P/E:

Trailing P/E Ratio: 28.13
Foreward P/E Ratio: 24.63
P/E Growth: 1.99

Sales & Book Value:

Annual Revenue: $961.62 million
Price / Sales: 1.23
Book Value: $23.51 per share
Price / Book: 2.76

Profitability:

EBIDTA: $92.03 million
Net Margins: 4.13%
Return on Equity: 9.62%
Return on Assets: 6.26%

Debt:

Debt-to-Equity Ratio: 0.19%
Current Ratio: 1.75%
Quick Ratio: 1.75%

Misc:

Average Volume: 160,489 shs.
Beta: 0.76
Short Ratio: 5.57

Frequently Asked Questions for LHC Group (NASDAQ:LHCG)

What is LHC Group's stock symbol?

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

How were LHC Group's earnings last quarter?

LHC Group (NASDAQ:LHCG) announced its earnings results on Wednesday, August, 2nd. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.54 by $0.09. The business had revenue of $260.20 million for the quarter, compared to the consensus estimate of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company's revenue was up 15.1% on a year-over-year basis. During the same period last year, the business posted $0.52 EPS. View LHC Group's Earnings History.

When will LHC Group make its next earnings announcement?

LHC Group is scheduled to release their next quarterly earnings announcement on Wednesday, November, 1st 2017. View Earnings Estimates for LHC Group.

What guidance has LHC Group issued on next quarter's earnings?

LHC Group issued an update on its FY17 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share (EPS) guidance of $2.30-2.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.28. The company issued revenue guidance of $1.03-1.045 billion, compared to the consensus revenue estimate of $1.03 billion.

Where is LHC Group's stock going? Where will LHC Group's stock price be in 2017?

9 equities research analysts have issued 12-month price targets for LHC Group's shares. Their predictions range from $56.00 to $76.00. On average, they expect LHC Group's share price to reach $66.56 in the next year. View Analyst Ratings for LHC Group.

Who are some of LHC Group's key competitors?

Some companies that are related to LHC Group include Ironwood Pharmaceuticals (IRWD), Myriad Genetics (MYGN), Intrexon Corporation (XON), LifePoint Health (LPNT), Halozyme Therapeutics (HALO), Ultragenyx Pharmaceutical (RARE), Haemonetics Corporation (HAE), The Advisory Board Company (ABCO), Halyard Health (HYH), Inogen (INGN), Brookdale Senior Living (BKD), Merit Medical Systems (MMSI), Corcept Therapeutics Incorporated (CORT), DBV Technologies S.A. (DBVT), Array BioPharma (ARRY), Horizon Pharma PLC (HZNP), Aerie Pharmaceuticals (AERI) and AMN Healthcare Services (AMN).

Who are LHC Group's key executives?

LHC Group's management team includes the folowing people:

Keith G. Myers, Chairman of the Board, Chief Executive Officer
Donald D. Stelly, President, Chief Operating Officer
Joshua L. Proffitt, Chief Financial Officer, Executive Vice President, Treasurer
W. J. Tauzin, Lead Independent Director
John L. Indest, Director
Monica F. Azare, Independent Director
John B. Breaux, Independent Director
Ronald T. Nixon, Independent Director

Who owns LHC Group stock?

LHC Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.11%), FMR LLC (8.77%), Vanguard Group Inc. (8.26%), Dimensional Fund Advisors LP (7.19%), Ameriprise Financial Inc. (3.27%) and Rothschild Asset Management Inc. (3.00%). Company insiders that own LHC Group stock include Coliseum Capital Management, L, Donald Dwayne Stelly, Joshua L Proffitt, Keith G Myers, Kenneth E Thorpe and Ronald T Nixon. View Institutional Ownership Trends for LHC Group.

Who sold LHC Group stock? Who is selling LHC Group stock?

LHC Group's stock was sold by a variety of institutional investors in the last quarter, including Walthausen & Co. LLC, FMR LLC, State of Tennessee Treasury Department, First Light Asset Management LLC, GSA Capital Partners LLP, Wasatch Advisors Inc., Boston Partners and Kornitzer Capital Management Inc. KS. Company insiders that have sold LHC Group stock in the last year include Coliseum Capital Management, L, Donald Dwayne Stelly, Joshua L Proffitt and Keith G Myers. View Insider Buying and Selling for LHC Group.

Who bought LHC Group stock? Who is buying LHC Group stock?

LHC Group's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Royal Bank of Canada, Castleark Management LLC, AJO LP, Northern Trust Corp, Alliancebernstein L.P., New York State Common Retirement Fund and EAM Investors LLC. View Insider Buying and Selling for LHC Group.

How do I buy LHC Group stock?

Shares of LHC Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is LHC Group's stock price today?

One share of LHC Group stock can currently be purchased for approximately $64.79.

MarketBeat Community Rating for LHC Group (NASDAQ LHCG)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		168 (Vote Outperform)
Underperform Votes:		185 (Vote Underperform)
Total Votes:		353

MarketBeat's community ratings are surveys of what our community members think about LHC Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for LHC Group (NASDAQ:LHCG) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	1 Hold Rating, 8 Buy Ratings
Consensus Rating:	Buy (Score: 2.89)
Consensus Price Target:	$66.56 (2.73% upside)

Analysts' Ratings History for LHC Group (NASDAQ:LHCG)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
9/12/2017	Robert W. Baird	Reiterated Rating	Hold	$63.00	Low
9/6/2017	Royal Bank Of Canada	Reiterated Rating	Buy	$70.00	Low
8/21/2017	Bank of America Corporation	Initiated Coverage	Buy -> Buy	$76.00	Low
8/4/2017	Jefferies Group LLC	Reiterated Rating	Buy	$68.00	Medium
6/8/2017	Benchmark Co.	Boost Price Target	Buy -> Buy	$63.00 -> $72.00	Medium
5/8/2017	Oppenheimer Holdings, Inc.	Reiterated Rating	Outperform	$55.00 -> $68.00	Low
5/6/2017	Stephens	Set Price Target	Buy	$69.00	Low
3/11/2017	Craig Hallum	Set Price Target	Buy	$57.00	High
3/10/2017	SunTrust Banks, Inc.	Upgrade	Hold -> Buy	$50.00 -> $56.00	High
2/29/2016	Piper Jaffray Companies	Reiterated Rating	Buy	$45.00 -> $55.00	N/A

(Data available from 9/20/2015 forward)

Earnings History for LHC Group (NASDAQ:LHCG)

Earnings by Quarter for LHC Group (NASDAQ:LHCG)

Earnings History by Quarter for LHC Group (NASDAQ LHCG)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/31/2017							N/A
8/2/2017	Q2 2017	$0.54	$0.63	$254.10 million	$260.20 million	View	Listen
3/8/2017	Q4 2016	$0.57	$0.58	$233.82 million	$235.44 million	View	Listen
11/2/2016	Q316	$0.50	$0.54	$224.60 million	$230.00 million	View	N/A
8/3/2016	Q2	$0.52	$0.52	$221.09 million	$226.00 million	View	N/A
5/4/2016	Q116	$0.37	$0.44	$214.41 million	$222.60 million	View	Listen
3/2/2016	Q415	$0.46	$0.53	$213.35 million	$219.00 million	View	N/A
11/4/2015	Q315	$0.43	$0.50	$199.40 million	$204.10 million	View	Listen
8/5/2015	Q215	$0.41	$0.51	$193.75 million	$200.20 million	View	Listen
5/6/2015	Q115	$0.35	$0.39	$188.90 million	$193.10 million	View	N/A
2/25/2015	Q414	$0.33	$0.45	$190.25 million	$193.40 million	View	Listen
11/5/2014	Q314	$0.34	$0.36	$185.00 million	$187.70 million	View	N/A
8/6/2014	Q214	$0.32	$0.35	$179.90 million	$188.90 million	View	Listen
5/7/2014	Q114	$0.27	$0.24	$166.15 million	$163.70 million	View	Listen
3/5/2014	Q413	$0.32	$0.29	$168.74 million	$165.30 million	View	Listen
11/6/2013	Q313	$0.31	$0.31	$167.61 million	$164.70 million	View	N/A
8/7/2013	Q2 2013	$0.28	$0.34	$166.50 million	$166.30 million	View	N/A
5/8/2013	Q1 2013	$0.33	$0.37	$164.68 million	$162.00 million	View	N/A
3/6/2013	Q4 2012	$0.37	$0.43	$160.93 million	$161.80 million	View	N/A
11/7/2012	Q312	$0.37	$0.36	$159.89 million	$158.90 million	View	N/A
8/6/2012		$0.39	$0.35			View	N/A
5/2/2012		$0.36	$0.44			View	N/A
2/29/2012		$0.35	$0.39			View	N/A
11/2/2011		$0.56	($2.08)			View	N/A
8/3/2011		$0.50	$0.56			View	N/A
5/5/2011		$0.36	$0.42			View	N/A
3/2/2011		$0.66	$0.63			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for LHC Group (NASDAQ:LHCG)

2017 EPS Consensus Estimate: $2.23
2018 EPS Consensus Estimate: $2.61

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	2	$0.44	$0.44	$0.44
Q2 2017	2	$0.54	$0.55	$0.55
Q3 2017	3	$0.56	$0.65	$0.60
Q4 2017	3	$0.60	$0.69	$0.64
Q1 2018	2	$0.55	$0.59	$0.57
Q2 2018	2	$0.66	$0.69	$0.68
Q3 2018	2	$0.64	$0.67	$0.66
Q4 2018	2	$0.70	$0.72	$0.71
Q1 2019	1	$0.66	$0.66	$0.66
Q2 2019	1	$0.72	$0.72	$0.72

(Data provided by Zacks Investment Research)

Dividend History for LHC Group (NASDAQ:LHCG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading and Institutional Ownership History for LHC Group (NASDAQ:LHCG)

Insider Ownership Percentage: 14.80%
Institutional Ownership Percentage: 85.93%

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Insider Trades by Quarter for LHC Group (NASDAQ:LHCG)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/8/2017	Donald Dwayne Stelly	COO	Sell	2,650	$65.34	$173,151.00
6/16/2017	Coliseum Capital Management, L	Director	Sell	14,450	$65.69	$949,220.50
6/9/2017	Coliseum Capital Management, L	Director	Sell	10,215	$65.14	$665,405.10
6/8/2017	Donald Dwayne Stelly	COO	Sell	3,181	$64.97	$206,669.57
6/7/2017	Coliseum Capital Management, L	Director	Sell	162,524	$62.80	$10,206,507.20
6/6/2017	Coliseum Capital Management, L	Director	Sell	25,000	$63.23	$1,580,750.00
6/5/2017	Coliseum Capital Management, L	Director	Sell	77,524	$61.73	$4,785,556.52
6/2/2017	Coliseum Capital Management, L	Director	Sell	145,850	$61.05	$8,904,142.50
5/30/2017	Coliseum Capital Management, L	Director	Sell	107,463	$60.63	$6,515,481.69
5/19/2017	Coliseum Capital Management, L	Director	Sell	8,632	$60.25	$520,078.00
5/11/2017	Coliseum Capital Management, L	Director	Sell	128,000	$60.99	$7,806,720.00
3/17/2017	Coliseum Capital Management, L	Director	Sell	51,900	$50.26	$2,608,494.00
3/15/2017	Joshua L Proffitt	Insider	Sell	6,984	$51.54	$359,955.36
3/13/2017	Donald Dwayne Stelly	COO	Sell	13,154	$51.81	$681,508.74
12/16/2016	Keith G Myers	CEO	Sell	31,139	$43.91	$1,367,313.49
12/13/2016	Keith G Myers	CEO	Sell	33,261	$43.58	$1,449,514.38
12/12/2016	Coliseum Capital Management, L	Director	Sell	50,100	$43.41	$2,174,841.00
12/1/2016	Coliseum Capital Management, L	Director	Sell	26,000	$42.70	$1,110,200.00
11/29/2016	Coliseum Capital Management, L	Director	Sell	18,228	$43.29	$789,090.12
11/29/2016	Keith G Myers	CEO	Sell	15,652	$43.64	$683,053.28
11/23/2016	Keith G Myers	CEO	Sell	44,897	$43.54	$1,954,815.38
11/22/2016	Keith G Myers	CEO	Sell	7,214	$43.53	$314,025.42
11/21/2016	Keith G Myers	CEO	Sell	18,423	$43.54	$802,137.42
11/18/2016	Keith G Myers	CEO	Sell	2,203	$43.53	$95,896.59
11/17/2016	Coliseum Capital Management, L	Director	Sell	45,776	$43.19	$1,977,065.44
11/16/2016	Keith G Myers	CEO	Sell	37,848	$43.69	$1,653,579.12
11/7/2016	Donald Dwayne Stelly	COO	Sell	2,651	$41.54	$110,122.54
11/7/2016	Joshua L Proffitt	Insider	Sell	2,098	$41.80	$87,696.40
8/22/2016	Kenneth E Thorpe	Director	Sell	1,450	$36.88	$53,476.00
6/10/2016	Joshua L Proffitt	EVP	Sell	5,444	$42.65	$232,186.60
6/9/2016	Coliseum Capital Management, L	Director	Sell	140,000	$43.64	$6,109,600.00
6/8/2016	Donald Dwayne Stelly	COO	Sell	1,326	$43.55	$57,747.30
5/27/2016	Keith G Myers	CEO	Sell	49,000	$41.09	$2,013,410.00
5/25/2016	Keith G Myers	CEO	Sell	126,000	$41.96	$5,286,960.00
5/24/2016	Keith G Myers	CEO	Sell	75,000	$42.19	$3,164,250.00
5/23/2016	Keith G Myers	CEO	Sell	21,000	$41.16	$864,360.00
3/14/2016	Donald Dwayne Stelly	COO	Sell	12,952	$35.51	$459,925.52
2/3/2016	Keith G Myers	CEO	Sell	55,000	$36.60	$2,013,000.00
1/5/2016	Keith G Myers	CEO	Sell	55,000	$43.13	$2,372,150.00
1/4/2016	Keith G Myers	CEO	Sell	24,300	$43.47	$1,056,321.00
12/11/2015	Coliseum Capital Management, L	Director	Sell	54,000	$45.90	$2,478,600.00
12/2/2015	Coliseum Capital Management, L	Director	Sell	24,549	$46.13	$1,132,445.37
12/2/2015	Keith G Myers	CEO	Sell	55,000	$46.20	$2,541,000.00
12/1/2015	Coliseum Capital Management, L	Director	Sell	124,905	$46.09	$5,756,871.45
11/30/2015	Coliseum Capital Management, L	Director	Sell	18,580	$47.09	$874,932.20
11/27/2015	Ronald T Nixon	Director	Sell	1,695	$48.06	$81,461.70
11/18/2015	Donald Dwayne Stelly	COO	Sell	1,353	$45.36	$61,372.08
11/17/2015	Coliseum Capital Management, L	Director	Sell	56,017	$45.48	$2,547,653.16
11/12/2015	Coliseum Capital Management, L	Director	Sell	78,000	$47.24	$3,684,720.00
11/9/2015	Donald Dwayne Stelly	COO	Sell	4,732	$47.35	$224,060.20
11/2/2015	Keith G Myers	CEO	Sell	55,000	$45.67	$2,511,850.00
10/5/2015	Keith G Myers	CEO	Sell	55,000	$43.28	$2,380,400.00
9/11/2015	Coliseum Capital Management, L	Director	Sell	285,846	$46.67	$13,340,432.82
9/8/2015	Coliseum Capital Management, L	Director	Sell	147,671	$46.96	$6,934,630.16
9/1/2015	Keith G Myers	CEO	Sell	55,000	$43.54	$2,394,700.00
8/19/2015	Coliseum Capital Management, L	Director	Sell	13,818	$47.68	$658,842.24
8/17/2015	Coliseum Capital Management, L	Director	Sell	77,390	$47.56	$3,680,668.40
7/7/2015	Keith G Myers	CEO	Sell	21,651	$37.47	$811,262.97
7/2/2015	Keith G Myers	CEO	Sell	33,349	$37.31	$1,244,251.19
6/12/2015	Coliseum Capital Management, L	Director	Sell	169,987	$36.51	$6,206,225.37
6/9/2015	Coliseum Capital Management, L	Director	Sell	15,606	$36.36	$567,434.16
6/9/2015	Donald Dwayne Stelly	COO	Sell	1,724	$36.20	$62,408.80
6/5/2015	Coliseum Capital Management, L	Director	Sell	88,494	$36.29	$3,211,447.26
6/4/2015	Ronald T Nixon	Director	Sell	4,000	$36.25	$145,000.00
6/3/2015	Keith G Myers	CEO	Sell	16,800	$36.04	$605,472.00
6/2/2015	Keith G Myers	CEO	Sell	38,200	$36.96	$1,411,872.00
5/6/2015	Keith G Myers	CEO	Sell	17,505	$30.09	$526,725.45
5/5/2015	Keith G Myers	CEO	Sell	37,495	$31.22	$1,170,593.90
3/12/2015	Donald Dwayne Stelly	COO	Sell	11,753	$32.27	$379,269.31
3/12/2015	Joshua L Proffitt	EVP	Sell	3,317	$32.37	$107,371.29
9/8/2014	Donald Dwayne Stelly	COO	Sell	4,732	$24.98	$118,205.36
8/27/2014	Keith G Myers	CEO	Sell	48,018	$25.66	$1,232,141.88
8/22/2014	Keith G Myers	CEO	Sell	24,234	$25.24	$611,666.16
8/21/2014	John L Indest	Director	Sell	4,200	$25.22	$105,924.00
8/21/2014	Keith G Myers	CEO	Sell	44,631	$25.23	$1,126,040.13
8/20/2014	Coliseum Capital Management, L	Director	Sell	62,000	$25.32	$1,569,840.00
8/20/2014	Keith G Myers	CEO	Sell	77,351	$25.33	$1,959,300.83
8/18/2014	Coliseum Capital Management, L	Director	Sell	158,011	$25.60	$4,045,081.60
8/18/2014	Donald Dwayne Stelly	COO	Sell	1,725	$25.62	$44,194.50
8/18/2014	Joshua L Proffitt	EVP	Sell	1,294	$25.58	$33,100.52
5/13/2014	Donald Dwayne Stelly	COO	Sell	10,472	$21.08	$220,749.76
5/12/2014	Joshua Proffitt	EVP	Sell	1,908	$21.13	$40,316.04
3/14/2014	Ted Hoyt	Director	Sell	5,000	$21.85	$109,250.00
3/10/2014	Ted Hoyt	Director	Sell	5,000	$22.35	$111,750.00
9/10/2013	Donald Dwayne Stelly	COO	Sell	1,354	$23.05	$31,209.70
8/13/2013	Donald Dwayne Stelly	COO	Sell	1,723	$26.08	$44,935.84
8/12/2013	Ted Hoyt	Director	Sell	1,000	$26.36	$26,360.00
6/13/2013	Keith G Myers	CEO	Sell	9,662	$22.91	$221,356.42
6/12/2013	Keith G Myers	CEO	Sell	61,500	$22.44	$1,380,060.00
6/11/2013	Coliseum Capital Management, L	Director	Buy	14,000	$22.20	$310,800.00
6/7/2013	Keith G Myers	CEO	Sell	11,547	$22.08	$254,957.76
6/4/2013	Keith G Myers	CEO	Sell	33,000	$22.45	$740,850.00
5/30/2013	Keith G Myers	CEO	Sell	32,738	$22.51	$736,932.38
5/24/2013	Keith G Myers	CEO	Sell	26,553	$22.54	$598,504.62
5/13/2013	John L Indest	Director	Sell	5,900	$22.76	$134,284.00
3/15/2013	Coliseum Capital Management, L	Director	Buy	27,201	$21.18	$576,117.18
3/12/2013	Coliseum Capital Management, L	Director	Buy	128,400	$19.89	$2,553,876.00
12/14/2012	Coliseum Capital Management, L	Director	Buy	44,100	$20.49	$903,609.00
12/4/2012	Donald Dwayne Stelly	COO	Sell	4,117	$19.52	$80,363.84
11/29/2012	Coliseum Capital Management, L	Director	Buy	101,200	$18.75	$1,897,500.00
9/5/2012	Coliseum Capital Management, L	Major Shareholder	Buy	34,947	$17.45	$609,825.15
8/8/2012	Coliseum Capital Management, L	Major Shareholder	Buy	84,546	$16.54	$1,398,390.84

(Data available from 1/1/2013 forward)

Headline Trends for LHC Group (NASDAQ:LHCG) Latest Headlines for LHC Group (NASDAQ:LHCG)

Source:

Date	Headline
	LHC Group (LHCG) Expected to Post Q1 2019 Earnings of $0.66 Per Share www.americanbankingnews.com - September 18 at 7:18 AM
	Zacks: Analysts Expect LHC Group (LHCG) Will Announce Quarterly Sales of $264.15 Million www.americanbankingnews.com - September 18 at 3:50 AM
	LHC Group (LHCG) vs. R1 RCM (RCM) Financial Survey www.americanbankingnews.com - September 17 at 10:16 AM
	LHC Group (LHCG) Expected to Post Earnings of $0.60 Per Share www.americanbankingnews.com - September 16 at 10:18 PM
	Critical Analysis: LHC Group (LHCG) vs. R1 RCM (RCM) www.americanbankingnews.com - September 16 at 6:14 AM
	Analyzing LHC Group (LHCG) & R1 RCM (RCM) www.americanbankingnews.com - September 15 at 6:52 AM
	LHC Group (LHCG) Stock Rating Reaffirmed by Robert W. Baird www.americanbankingnews.com - September 12 at 9:28 PM
	Insider Selling: LHC Group (LHCG) COO Sells 2,650 Shares of Stock www.americanbankingnews.com - September 8 at 8:20 PM
	Royal Bank Of Canada Reaffirms "Buy" Rating for LHC Group (LHCG) www.americanbankingnews.com - September 6 at 9:40 PM
	LHC Group (LHCG), CHRISTUS Health Finalize JV Agreement www.streetinsider.com - September 2 at 5:12 AM
	BRIEF-LHC Group and Christus Health finalize joint venture agreement www.reuters.com - September 2 at 5:12 AM
	LHC Group and CHRISTUS Health Finalize Joint Venture Agreement finance.yahoo.com - September 2 at 5:12 AM
	LHC Group to Present at Baird 2017 Global Healthcare Conference feeds.benzinga.com - August 30 at 11:13 AM
	LHC Group, Inc. breached its 50 day moving average in a Bullish Manner : LHCG-US : August 29, 2017 finance.yahoo.com - August 30 at 5:53 AM
	LHC Group (LHCG) Given Average Rating of "Buy" by Analysts www.americanbankingnews.com - August 29 at 8:50 PM
	Zacks: Analysts Anticipate LHC Group (LHCG) to Announce $0.60 EPS www.americanbankingnews.com - August 29 at 10:18 AM
	ETFs with exposure to LHC Group, Inc. : August 21, 2017 finance.yahoo.com - August 22 at 8:33 PM
	LHC Group (LHCG) Now Covered by Analysts at Bank of America Corporation www.americanbankingnews.com - August 21 at 9:32 AM
	LHC Group (LHCG) Stock Rating Upgraded by BidaskClub www.americanbankingnews.com - August 18 at 10:16 PM
	LHC Group, Inc. breached its 50 day moving average in a Bullish Manner : LHCG-US : August 16, 2017 finance.yahoo.com - August 16 at 3:50 PM
	Company Profile for LHC Group finance.yahoo.com - August 12 at 2:32 AM
	$0.60 EPS Expected for LHC Group (LHCG) This Quarter www.americanbankingnews.com - August 11 at 12:14 AM
	LHC Group, Inc. :LHCG-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017 finance.yahoo.com - August 10 at 2:13 AM
	LHC Group’s CMS Star Ratings Continue to Lead Home Healthcare Industry finance.yahoo.com - August 8 at 8:15 PM
	SunTrust Banks Analysts Raise Earnings Estimates for LHC Group (LHCG) www.americanbankingnews.com - August 7 at 7:40 AM
	LHC Group (LHCG) Rating Increased to Buy at Zacks Investment Research www.americanbankingnews.com - August 6 at 9:26 AM
	LHC Group (NASDAQ:LHCG) Earns Buy Rating from Jefferies Group LLC www.americanbankingnews.com - August 5 at 7:14 AM
	LHC Group (NASDAQ:LHCG) Receives Consensus Recommendation of "Buy" from Brokerages www.americanbankingnews.com - August 4 at 8:28 PM
	LHC Group Expected to Post FY2017 Earnings of $2.36 Per Share (NASDAQ:LHCG) www.americanbankingnews.com - August 4 at 10:46 AM
	Q3 2017 EPS Estimates for LHC Group (NASDAQ:LHCG) Boosted by Jefferies Group www.americanbankingnews.com - August 4 at 7:16 AM
	LHC Group (LHCG) & CHRISTUS Health Announce JV Agreement to Enhance 21 Home Health Service Locations www.streetinsider.com - August 4 at 12:08 AM
	LHC Group's (LHCG) CEO Keith Myers on Q2 2017 Results - Earnings Call Transcript seekingalpha.com - August 4 at 12:08 AM
	Edited Transcript of LHCG earnings conference call or presentation 3-Aug-17 3:00pm GMT finance.yahoo.com - August 4 at 12:07 AM
	LHC tops Street 2Q forecasts finance.yahoo.com - August 4 at 12:07 AM
	LHC Group Second Quarter Earnings Per Diluted Share Increase 16.7% to $0.63 on 15.1% Growth in Revenue to $260.2 Million finance.yahoo.com - August 3 at 2:54 AM
	LHC Group (NASDAQ:LHCG) Releases FY17 Earnings Guidance www.americanbankingnews.com - August 2 at 9:26 PM
	LHC Group and CHRISTUS Health Announce Joint Venture Agreement finance.yahoo.com - August 2 at 3:07 AM
	LHC Group, Inc. – Value Analysis (NASDAQ:LHCG) : August 1, 2017 finance.yahoo.com - August 2 at 3:07 AM
	LHC Group is Now Oversold (LHCG) www.nasdaq.com - July 28 at 2:06 AM
	LHC Group (LHCG) Set to Announce Earnings on Wednesday www.americanbankingnews.com - July 27 at 12:59 PM
	Head to Head Review: LHC Group (LHCG) versus R1 RCM (ACHI) www.americanbankingnews.com - July 23 at 4:21 PM
	Brokerages Expect LHC Group (NASDAQ:LHCG) Will Post Quarterly Sales of $252.84 Million www.americanbankingnews.com - July 23 at 8:06 AM
	LHC Group, Inc. breached its 50 day moving average in a Bearish Manner : LHCG-US : July 19, 2017 finance.yahoo.com - July 20 at 12:17 AM
	LHC Group Announces Second Quarter 2017 Earnings Release and Conference Call Dates finance.yahoo.com - July 20 at 12:17 AM
	ETFs with exposure to LHC Group, Inc. : July 10, 2017 finance.yahoo.com - July 11 at 12:11 AM
	LHC Group (NASDAQ:LHCG) Receives Average Recommendation of "Buy" from Brokerages www.americanbankingnews.com - July 10 at 8:32 PM
	LHC Group (LHCG) Downgraded by Zacks Investment Research www.americanbankingnews.com - July 9 at 10:32 AM
	Strange: Bullish LHCG Analysts Actually See -6.93% Downside www.nasdaq.com - July 7 at 6:57 AM
	$253.79 Million in Sales Expected for LHC Group (LHCG) This Quarter www.americanbankingnews.com - June 29 at 11:02 AM
	LHC Group (LHCG) Expected to Post Earnings of $0.55 Per Share www.americanbankingnews.com - June 27 at 2:16 PM